Search Results

You are looking at 91 - 100 of 5,003 items for :

  • "treatment" x
  • Medical and Health Sciences x
  • Refine by Access: All Content x
Clear All

2025 Ardissino, D., Savonitto, S., Egstrup, K. és mtsai: Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise

Restricted access

McMurray, J. J., Adamopoulos, S., Anker, S. D., et al.: ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of

Open access

729 Schulman, S., Kearon, C., Kakkar, A. J. és mtsai for the RE-COVER Study group: Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N. Engl. J. Med

Open access

trials. JAMA, 1994, 272 (24), 1932–1938. 3 Kiss, I., (ed.): Treatment of hypertension disease. [A hypertoniabetegség ellátása.] Hypertonia és Nephrologia, 2015

Open access

, tapered tooth shape, and presence of dehiscence/fenestration are also common risk factors for gingival recession [ 10–12 ]. Orthodontic treatment is considered to be an iatrogenic factor that contributes to gingival recession [ 11 , 13 , 14

Open access

és Csont, 2009, 12 (3), 103–107. [Hungarian] 15 Lakatos, P., Tóth, E., Szekeres, L., et al.: Efficiency of osteoporosis treatment in Hungary – an analysis of

Restricted access

Watts, N. B., Bilezikian, J. P., Camacho, P. M. és mtsai: American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr. Pract., 2010, 16 (Suppl. 3) , 1

Restricted access

Parekh, D.: Laparoscopic-assisted pancreatic necrosectomy. A new surgical option for treatment of severe necrotizing pancreatitis. Arch. Surg., 2006, 141 , 895–903. Parekh D

Restricted access

696 701 Jeong, S., Aikata, H., Katamura, Y. és mtsai: Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of

Open access

Kwo, P. Y., Lawitz, E. J., McCone, J. és mtsai: Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open

Restricted access